Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Hutton

Showing results (251-260 of 352) with videos related to

Pageof 36
Sort By:
BMJ Open|April 29, 2022
Design and methodological characteristics of studies using observational routinely collected health data for investigating the link between cancer and neurodegenerative diseases: protocol for a meta-research studyFerrán Catalá-López, Jane A Driver, Matthew J Page, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 1, 2020
A randomized trial comparing vascular access strategies for patients receiving chemotherapy with trastuzumab for early-stage breast cancerMark Clemons, Carol Stober, Anne Kehoe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 25, 2022
Using machine learning to predict individual patient toxicities from cancer treatmentsKatherine Marie Cole, Mark Clemons, Sharon McGee, et al.
Journal of Bone Oncology|January 11, 2021
Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancerArif Awan, Terry Ng, Henry Conter, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 13, 2018
Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC)Mark Clemons, Sasha Mazzarello, John Hilton, et al.
JAMA Network Open|November 22, 2023
Rapid Access Addiction Medicine Clinics for People With Problematic Opioid UseKim Corace, Kednapa Thavorn, Kelly Suschinsky, et al.
Systematic Reviews|August 27, 2015
Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: protocol for a systematic review incorporating network meta-analysesBrian Hutton, Fatemeh Yazdi, Louise Bordeleau, et al.
British Journal of Anaesthesia|July 4, 2025
Adherence to prehabilitation in adult surgical patients: a systematic review, meta-analysis, meta-regression, and qualitative synthesisMarta I Berrio-Valencia, Mariam Al-Bayati, Adir Baxi, et al.
Current Oncology (Toronto, Ont.)|December 23, 2021
A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast CancerSusan Dent, Dean Fergusson, Olexiy Aseyev, et al.
Leukemia & Lymphoma|May 10, 2018
Propensity score matching analysis to evaluate the comparative effectiveness of daratumumab versus real-world standard of care therapies for patients with heavily pretreated and refractory multiple myelomaShaji Kumar, Brian Durie, Hareth Nahi, et al.
Pageof 36

Showing results (251-260 of 352) with videos related to

Sort By:
Pageof 36
BMJ Open|April 29, 2022
Design and methodological characteristics of studies using observational routinely collected health data for investigating the link between cancer and neurodegenerative diseases: protocol for a meta-research studyFerrán Catalá-López, Jane A Driver, Matthew J Page, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 1, 2020
A randomized trial comparing vascular access strategies for patients receiving chemotherapy with trastuzumab for early-stage breast cancerMark Clemons, Carol Stober, Anne Kehoe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 25, 2022
Using machine learning to predict individual patient toxicities from cancer treatmentsKatherine Marie Cole, Mark Clemons, Sharon McGee, et al.
Journal of Bone Oncology|January 11, 2021
Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancerArif Awan, Terry Ng, Henry Conter, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 13, 2018
Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC)Mark Clemons, Sasha Mazzarello, John Hilton, et al.
JAMA Network Open|November 22, 2023
Rapid Access Addiction Medicine Clinics for People With Problematic Opioid UseKim Corace, Kednapa Thavorn, Kelly Suschinsky, et al.
Systematic Reviews|August 27, 2015
Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: protocol for a systematic review incorporating network meta-analysesBrian Hutton, Fatemeh Yazdi, Louise Bordeleau, et al.
British Journal of Anaesthesia|July 4, 2025
Adherence to prehabilitation in adult surgical patients: a systematic review, meta-analysis, meta-regression, and qualitative synthesisMarta I Berrio-Valencia, Mariam Al-Bayati, Adir Baxi, et al.
Current Oncology (Toronto, Ont.)|December 23, 2021
A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast CancerSusan Dent, Dean Fergusson, Olexiy Aseyev, et al.
Leukemia & Lymphoma|May 10, 2018
Propensity score matching analysis to evaluate the comparative effectiveness of daratumumab versus real-world standard of care therapies for patients with heavily pretreated and refractory multiple myelomaShaji Kumar, Brian Durie, Hareth Nahi, et al.
Pageof 36